PANAGORA ASSET MANAGEMENT INC - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 123 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
PANAGORA ASSET MANAGEMENT INC ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$121,078
-84.5%
29,676
-81.0%
0.00%
-80.0%
Q4 2022$782,728
-58.5%
155,922
+8.2%
0.01%
-61.5%
Q3 2022$1,885,000
+54.0%
144,144
+50.9%
0.01%
+62.5%
Q2 2022$1,224,000
+10.3%
95,505
+31.2%
0.01%
+33.3%
Q1 2022$1,110,000
-6.6%
72,816
+8.6%
0.01%0.0%
Q4 2021$1,188,00067,0660.01%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,766,666$79,175,00044.14%
Ponoi II Management, LLC 1,298,908$27,303,00040.46%
Column Group LLC 15,396,116$323,626,00036.81%
Ponoi Management, LLC 1,298,908$27,303,00024.24%
Euclidean Capital LLC 832,274$17,494,0008.50%
StepStone Group LP 1,573,357$33,072,0002.14%
Octagon Capital Advisors LP 200,000$4,204,0001.04%
Redmile Group, LLC 2,505,118$52,658,0000.92%
BVF INC/IL 955,000$20,074,0000.78%
Boxer Capital, LLC 500,000$10,510,0000.37%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders